Towards evidence-based and personalised care of acute pancreatitis.
Guillermo García-RayadoKarina Cárdenas-JaénEnrique de MadariaPublished in: United European gastroenterology journal (2020)
Acute pancreatitis is a heterogeneous illness. Most patients experience a mild course of disease, but one third will develop local complications and/or organ failure associated with increased morbidity and risk of mortality. Diagnosis of acute pancreatitis is based on typical epigastric pain, elevation of serum lipase or amylase levels, and/or characteristic findings on imaging. Personalised management is needed in patients with acute pancreatitis. Currently, analgesia, Ringer's lactate solution-based goal-directed fluid resuscitation and early oral refeeding providing enteral nutrition if not tolerated are the cornerstones for early management. Prophylactic antibiotics or endoscopic retrograde cholangiopancreatography in the absence of cholangitis are considered to be futile. Future clinical trials should address optimal fluid resuscitation, the early administration of anti-inflammatory drugs and the exact role of nutritional support in severe acute pancreatitis. Here, we present a patient case and review the diagnosis, treatment and prognosis of acute pancreatitis.
Keyphrases
- clinical trial
- cardiac arrest
- pain management
- healthcare
- newly diagnosed
- chronic pain
- risk factors
- palliative care
- cardiovascular disease
- anti inflammatory drugs
- neuropathic pain
- type diabetes
- early onset
- prognostic factors
- case report
- quality improvement
- cardiovascular events
- chronic kidney disease
- postoperative pain
- density functional theory
- patient reported outcomes
- current status
- ulcerative colitis
- fluorescence imaging
- drug induced
- endoscopic submucosal dissection
- breast reconstruction